Key result
Various active ginsenosides from Panax ginseng exhibit pharmacological functions against atherosclerosis through multiple underlying mechanisms, providing insights for novel anti-cardiovascular drugs.
Why the study?
Atherosclerosis remains a leading cause of cardiovascular disease despite current therapies, prompting the need for reliable therapeutic agents such as ginsenosides to cure or alleviate atherosclerosis.
Ginsenosides from Panax ginseng exhibit various pharmacological activities that may provide useful insights for developing novel therapies for atherosclerosis.
No takes yet. Share an insight, caveat, or question.
Should not change clinical practice; leaves open translation of ginsenosides into anti-atherosclerotic therapies.
Xue et al. (2020) conducted a review in Atherosclerosis. Ginsenosides from Panax ginseng was evaluated. Various active ginsenosides from Panax ginseng exhibit pharmacological functions against atherosclerosis through multiple underlying mechanisms, providing insights for novel anti-cardiovascular drugs.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: